Document is current
Any future updates will be listed below
-
Authors
Adler, Alma J. http://orcid.org/0000-0002-6700-3279
Laar, Amos K.
Kotoh, Agnes M.
Legido-Quigley, Helena
Perel, Pablo
Lamptey, Peter
Lange, Isabelle L.
-
Funding
Funding for this research was provided by:
Novartis
- License Information
-
More Information
Article History
Received: 30 October 2018
Accepted: 22 November 2019
First Online: 30 January 2020
Ethics approval and consent to participate
: The evaluation protocol was reviewed and approved by the Institutional Review Boards (IRBs) of LSHTM (LSHTM Ethics Ref: 10152), the Ghana Health Service (ID NO. GHS- RC 04/01/15), and the University of Ghana at Noguchi Memorial Institute for Medical Research (Ethics clearance # IRB00001276). Written informed consent was obtained from all participants. Prior to data collection, appropriate community entry procedures were followed. Key stakeholders and institutions were notified using introductory letters. Two community volunteers were recruited to facilitate fieldwork in the intervention and comparison districts.All participants whose SBP was greater than or equal to 140 mmHg or DBP > = 90 mmHg, were verbally referred to the nearest health facility for confirmation of diagnosis and management. The participants consented to the publication of this data.
: Participants’ written consent was obtained for the purposes of publishing the results from the study, and for direct anonymised quotes to be used in the publication.
: The co-authors PL, AKL, AK, PP, AJA, ILL and HL worked on the ComHIP Programme for which their institutions (LSHTM and UGSPH) have received grants from the Novartis Foundation.
